CUKUROVA MEDICAL JOURNAL, vol.46, no.4, pp.1401-1408, 2021 (ESCI)
Purpose: The aim of the present study was to evaluate survivin immunoexpression and the clinicopathologic correlations in serous borderline ovarian tumors (BOT) patients <= 40 years old.